13F-HR filed by Atle Fund Management AB
Atle Fund Management AB filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-04-25, with 44 holding rows worth $164,352,756.
- Accession
- 0001381843-24-000004
- Filer
- CIK 1381843
- Filed
- 2024-04-25
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 44 entries on the cover page, a total value of $164,352,756 stated on the cover page (in dollars after the unit check, H1), rows summing to $164,352,756 with VALUE read as dollars as filed, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Merck & Co.,Inc. | 58933Y105 | COM | 133,741 | $17,647,125 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 20,778 | $16,164,453 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 23,041 | $11,398,383 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 15,186 | $8,826,255 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 43,480 | $5,996,762 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 170,000 | $5,708,600 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 15,154 | $5,423,162 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 18,891 | $5,371,089 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 29,346 | $5,343,907 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 77,401 | $5,301,194 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 5,393 | $5,190,709 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 20,426 | $4,963,314 | dollars as filed | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 12,000 | $4,929,960 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 11,295 | $4,721,423 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 132,895 | $4,457,298 | dollars as filed | |
| Elevance Health, Inc. | 036752103 | COM | 7,400 | $3,837,196 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 52,000 | $3,809,000 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 26,283 | $3,645,452 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 123,000 | $3,089,760 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 27,500 | $3,077,250 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 252,307 | $2,972,176 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 138,836 | $2,959,984 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 63,791 | $2,765,340 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 40,899 | $2,658,435 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 38,050 | $2,633,060 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 10,058 | $2,543,568 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 24,775 | $2,367,499 | dollars as filed | |
| SHOCKWAVE MED INC | 82489T104 | COM | 4,751 | $1,547,068 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 38,000 | $1,491,120 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 77,540 | $1,322,832 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 17,496 | $1,216,847 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 6,624 | $1,178,608 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 37,841 | $1,170,044 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 16,120 | $1,113,247 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 24,325 | $1,095,355 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 4,782 | $1,027,126 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 14,000 | $981,540 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 3,539 | $945,055 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 49,307 | $725,799 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 24,432 | $617,152 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 96,345 | $614,681 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 22,394 | $529,618 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 14,952 | $526,310 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 100,000 | $448,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001381843-24-000004 | this filing | 2024-04-25 | acceptance time not in the bulk data set |